UOL-Hep-Rho0 cell line

This cell line consists of HepG2, Rho 0 line. This line has potential for researchers to use as a fusion partner with their choice of mitochondrial donor

Contributors

Inventor Institute
Amy Chadwick University of Liverpool, Molecular and Clinical Pharmacology
Cat. #: 161136
Research Fields: Drug development
Organism: Human
Tissue: Liver
Growth properties: Adherent
Product description: This cell line consists of HepG2 cybrid cell lines negative for cellular mitochondrial DNA, fused with different platelet partners (platelets contain only mitochondrial DNA and no nuclear DNA). Each cybrid cell line has a combination of SNPs in mitochondrial DNA, relevant to a variety of diseases. Cybrid cell line panel has potential use for drug testing
Additional notes: Parental cell line was purchased from ECACC
Parental cell line: HepG2
Model description: HepG2 Rho0 cell line (devoid of mitochondrial DNA)
Growth medium: DMEM/F-12 + GlutaMAXTM supplemented with FBS (10 % v/v), L-glutamine (4?mM), sodium pyruvate (1?mM), HEPES (2?mM) and uridine (500 ?M)
Subculture routine: Cells are subcultured as required (1:6), via trypsinisation, but media is changed twice weekly

Related Tools for Cell lines

Cat. # Tool Name
151503 1-7 CE1 Cell Line Key Info View Tool
151559 MEF UNG KO Cell Line Key Info View Tool
151579 U-2 OS Gal4-p300 Cell Line Key Info View Tool
151663 MEF PKCe KO KI Cell Line Key Info View Tool
151449 JIM1 Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.